ASPG and ovarian cancer: One in vitro study found that silencing asparagine synthase increased ovarian cancer cells’ sensitivity to L-asparaginase up to 500-fold, concluding that asparagine synthetase may be used as a predictor of L-asparaginase therapy efficacy [181].